BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu C, Xue Y, Liu MF, Wang Y, Chen L. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential. Neurochem Int 2020;138:104754. [PMID: 32422324 DOI: 10.1016/j.neuint.2020.104754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bian K, Liu C, Wang Y, Xue Y, Chen L. Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice. Neurosci Lett 2021;765:136291. [PMID: 34666119 DOI: 10.1016/j.neulet.2021.136291] [Reference Citation Analysis]
2 Mobed A, Razavi S, Ahmadalipour A, Shakouri SK, Koohkan G. Biosensors in Parkinson's disease. Clin Chim Acta 2021;518:51-8. [PMID: 33753044 DOI: 10.1016/j.cca.2021.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Azhar L, Kusumo RW, Marotta G, Lanctôt KL, Herrmann N. Pharmacological Management of Apathy in Dementia. CNS Drugs 2022. [PMID: 35006557 DOI: 10.1007/s40263-021-00883-0] [Reference Citation Analysis]
4 Mitroshina EV, Savyuk MO, Ponimaskin E, Vedunova MV. Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease. Front Cell Dev Biol 2021;9:703084. [PMID: 34395432 DOI: 10.3389/fcell.2021.703084] [Reference Citation Analysis]
5 Lajoie AC, Lafontaine AL, Kaminska M. The Spectrum of Sleep Disorders in Parkinson Disease: A Review. Chest 2021;159:818-27. [PMID: 32956712 DOI: 10.1016/j.chest.2020.09.099] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
6 Kumar S, Behl T, Sehgal A, Singh S, Sharma N, Bhatia S, Al-Harassi A, Abdel-Daim MM, Bungau S. Exploring the Role of Orexinergic Neurons in Parkinson's Disease. Neurotox Res 2021. [PMID: 34495449 DOI: 10.1007/s12640-021-00411-4] [Reference Citation Analysis]